Vita Life Sciences Limited (ASX:VLS)

Market Cap	123.83M
Revenue (ttm)	79.51M
Net Income (ttm)	8.78M
Shares Out	55.03M
EPS (ttm)	0.16
PE Ratio	14.25
Forward PE	n/a
Dividend	0.10 (4.44%)
Ex-Dividend Date	Mar 21, 2025

Volume	291
Average Volume	17,368
Open	2.295
Previous Close	2.250
Day's Range	2.250 - 2.295
52-Week Range	1.620 - 2.380
Beta	0.56
RSI	60.87
Earnings Date	Aug 21, 2025

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 350
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VLS

Financial Performance

In 2024, Vita Life Sciences's revenue was 79.51 million, an increase of 8.28% compared to the previous year's 73.43 million. Earnings were 8.78 million, a decrease of -3.26%.